A research-driven approach to optimizing stormwater biofiltration through strategic media amendments and system configuration. Combines biochar, carbon sources, and iron-based materials with a continuously submerged zone to enhance nitrogen removal while preventing phosphorus export.
This solution addresses a critical water quality challenge: removing nitrogen and other pollutants from stormwater runoff using enhanced biofiltration systems. The approach optimizes filter media composition and system configuration to improve nitrogen removal without causing phosphorus export, a common trade-off in conventional stormwater treatment.
The technology targets three key improvements: enhanced nitrogen removal through synergistic media amendments, improved dissolved organic carbon removal, and prevention of phosphorus leaching. These capabilities are relevant for municipalities, watershed districts, green infrastructure developers, and environmental engineering firms seeking effective stormwater treatment solutions.
Media composition strategy:
System configuration:
Performance assessment:
This technology is currently at an advanced laboratory and pilot-scale validation stage. Ongoing work includes systematic production and characterization of biochars and verification of pollutant removal performance at both lab and pilot scales. Promising results have been observed for dissolved organic carbon removal using high-temperature biochar and effective phosphate and nitrate removal using iron materials. Building on prior column studies demonstrating nitrate and dissolved organic carbon removal in vegetated biofiltration systems, the proposed research will optimize media composition and configuration to enhance nitrogen removal while preventing phosphorus export. The findings will directly inform improved design of amended biofiltration systems for broader water quality improvements.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.